000129366 001__ 129366
000129366 005__ 20210129211250.0
000129366 0247_ $$2doi$$a10.1016/j.ijdevneu.2012.10.005
000129366 0247_ $$2pmid$$apmid:23085082
000129366 0247_ $$2ISSN$$a0736-5748
000129366 0247_ $$2ISSN$$a1873-474X
000129366 0247_ $$2WOS$$aWOS:000313997300009
000129366 037__ $$aFZJ-2013-00882
000129366 041__ $$aeng
000129366 082__ $$a610
000129366 1001_ $$0P:(DE-Juel1)142514$$aJaeger, Alexandra$$b0
000129366 245__ $$aGlycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells.
000129366 260__ $$aOxford [u.a.]$$bPergamon Press$$c2013
000129366 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1359127353_29187
000129366 3367_ $$2DataCite$$aOutput Types/Journal article
000129366 3367_ $$00$$2EndNote$$aJournal Article
000129366 3367_ $$2BibTeX$$aARTICLE
000129366 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000129366 3367_ $$2DRIVER$$aarticle
000129366 500__ $$3POF3_Assignment on 2016-02-29
000129366 520__ $$aGlycogen synthase kinase-3beta is a multifunctional key regulator enzyme in neural developmental processes and a main component of the canonical Wnt signaling pathway. It is already known that the Wnt-driven differentiation of neural progenitor cells is accompanied by an increase of apoptosis at which the pro-apoptotic function of GSK-3beta is still discussed. The aim of the present study was to investigate whether the phosphorylation level of GSK-3beta at serine 9 is the primary regulatory mechanism of differentiation-induced apoptosis. Differentiating human neural ReNcell VM progenitor cells were treated with the specific GSK-3beta inhibitor SB216763 (10μM) and analyzed in respect to the intrinsic apoptosis pathway regulation using microscopy and protein expression analysis. Differentiation of ReNcell VM cells was accompanied by cell morphological changes, cytoskeleton rearrangement and apoptosis increase. Treatment of differentiating cells with SB216763 induced a significant dephosphorylation of GSK-3beta at serine 9 accompanied by a significant decrease of apoptosis of about 0.7±0.03% and reduced activation of caspase-3 as well as BAX and PARP cleavage during the first 12h of differentiation compared to untreated, differentiating cells. Dephosphorylation of GSK-3beta at serine 9 appears not solely to be responsible for its pro-apoptotic function, because we observed a decrease of intrinsic apoptosis after treatment of the cells with the specific GSK-3beta inhibitor SB216763. We assume that GSK-3beta drives neural progenitor cell apoptosis by direct interaction with pro-apoptotic BAX or by indirect influence on the canonical Wnt/beta-catenin target gene transcription.
000129366 536__ $$0G:(DE-HGF)POF2-899$$a899 - ohne Topic (POF2-899)$$cPOF2-899$$fPOF I$$x0
000129366 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de, PubMed,
000129366 7001_ $$0P:(DE-HGF)0$$aBaake, Jana$$b1
000129366 7001_ $$0P:(DE-HGF)0$$aWeiss, Dieter G$$b2
000129366 7001_ $$0P:(DE-Juel1)133469$$aKriehuber, Ralf$$b3$$eCorresponding author
000129366 773__ $$0PERI:(DE-600)2012538-0$$a10.1016/j.ijdevneu.2012.10.005$$gVol. 31, no. 1, p. 61 - 68$$n1$$p61 - 68$$tInternational journal of developmental neuroscience$$v31$$x0736-5748$$y2013
000129366 8564_ $$uhttps://juser.fz-juelich.de/record/129366/files/FZJ-2013-00882.pdf$$yRestricted$$zPublished final document.
000129366 909CO $$ooai:juser.fz-juelich.de:129366$$pVDB
000129366 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)142514$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000129366 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133469$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000129366 9132_ $$0G:(DE-HGF)POF3-899H$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vAddenda$$x0
000129366 9131_ $$0G:(DE-HGF)POF2-899$$1G:(DE-HGF)POF2-890$$2G:(DE-HGF)POF2-800$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000129366 9141_ $$y2013
000129366 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000129366 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000129366 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000129366 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000129366 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000129366 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000129366 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000129366 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000129366 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000129366 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000129366 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000129366 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000129366 9201_ $$0I:(DE-Juel1)S-US-20090406$$kS-US$$lSicherheit und Strahlenschutz, Umgebungsüberwachung,Strahlenbiologie$$x0
000129366 980__ $$aVDB
000129366 980__ $$ajournal
000129366 980__ $$aUNRESTRICTED
000129366 980__ $$aI:(DE-Juel1)S-US-20090406